Neurology and Neurosurgery

289-304 of 455

• 

  RestartResume

  Schizophrenia Diagnosis: The Importance of a Collaborative Approach

  RestartResume

  Schizophrenia Diagnosis: The Importance of a Collaborative Approach

  NeuroFrontiers

  Schizophrenia Diagnosis: The Importance of a Collaborative Approach

  • 

    

    Ashley Baker, MSN, PMHNP

  • 

    

    Morris Goldman, MD

  • 

    

    Dara Sanandaji

• 

  RestartResume

  Examining the Role of Toxic Tau Proteins in Alzheimer's Disease

  RestartResume

  Examining the Role of Toxic Tau Proteins in Alzheimer's Disease

  NeuroFrontiers

  Examining the Role of Toxic Tau Proteins in Alzheimer's Disease

  • 

    

    Andrew Wilner, MD, FACP, FAAN

  • 

    

    George Bloom, PhD

• 

  RestartResume

  New Study Shows EBV-Specific T-Cells Contribute to MS Development

  RestartResume

  New Study Shows EBV-Specific T-Cells Contribute to MS Development

  NeuroFrontiers

  New Study Shows EBV-Specific T-Cells Contribute to MS Development

  • 

    

    J. William Lindsey

• 

  RestartResume

  A Successful and Safe Stem Cell Therapy for Progressive MS

  RestartResume

  A Successful and Safe Stem Cell Therapy for Progressive MS

  NeuroFrontiers

  A Successful and Safe Stem Cell Therapy for Progressive MS

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

  • 

    

    Stefano Pluchino, MD, PhD

• 

  RestartResume

  Alzheimer’s Research: Opening the Blood-Brain Barrier with Aducanumab and Focused Ultrasound

  RestartResume

  Alzheimer’s Research: Opening the Blood-Brain Barrier with Aducanumab and Focused Ultrasound

  NeuroFrontiers

  Alzheimer’s Research: Opening the Blood-Brain Barrier with Aducanumab and Focused Ultrasound

  • 

    

    Andrew Wilner, MD, FACP, FAAN

  • 

    

    Marc Haut, PhD

• 

  RestartResume

  First Episode Psychosis: Improving Patient Outcomes Through Early Intervention  

  RestartResume

  First Episode Psychosis: Improving Patient Outcomes Through Early Intervention  

  NeuroFrontiers

  First Episode Psychosis: Improving Patient Outcomes Through Early Intervention  

  • 

    

    Ashley Baker, MSN, PMHNP

  • 

    

    Hannah Brown, MD

• 

  RestartResume

  Investigating the Clinical Utility of the Multiple Sclerosis Disease Activity Test

  RestartResume

  Investigating the Clinical Utility of the Multiple Sclerosis Disease Activity Test

  NeuroFrontiers

  Investigating the Clinical Utility of the Multiple Sclerosis Disease Activity Test

  • 

    

    Andrew Wilner, MD, FACP, FAAN

  • 

    

    William A. Kilgo, MD

• 

  RestartResume

  Adverse Childhood and Lifespan Stressors Take a Toll on MS Disease Severity

  RestartResume

  Adverse Childhood and Lifespan Stressors Take a Toll on MS Disease Severity

  NeuroFrontiers

  Adverse Childhood and Lifespan Stressors Take a Toll on MS Disease Severity

  • 

    

    Andrew Wilner, MD, FACP, FAAN

  • 

    

    Carri Polick, PhD, RN

• 

  RestartResume

  MS in Black and Hispanic Patients: Examining Prevalence and Disease Characteristics

  RestartResume

  MS in Black and Hispanic Patients: Examining Prevalence and Disease Characteristics

  NeuroFrontiers

  MS in Black and Hispanic Patients: Examining Prevalence and Disease Characteristics

  • 

    

    Jennifer Caudle, DO, FACOFP

  • 

    

    Mitzi Joi Williams, MD

• 

  RestartResume

  Mind Matters: Psychiatric Comorbidity in the Prodromal Phase of MS

  RestartResume

  Mind Matters: Psychiatric Comorbidity in the Prodromal Phase of MS

  NeuroFrontiers

  Mind Matters: Psychiatric Comorbidity in the Prodromal Phase of MS

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

  • 

    

    Anibal Chertcoff, MD

• 

  RestartResume

  Examining Emerging Gut Microbiota Biomarkers for MS

  RestartResume

  Examining Emerging Gut Microbiota Biomarkers for MS

  NeuroFrontiers

  Examining Emerging Gut Microbiota Biomarkers for MS

• 

  RestartResume

  MS in Children: Exploring Biomarker Research Advancements

  RestartResume

  MS in Children: Exploring Biomarker Research Advancements

  NeuroFrontiers

  MS in Children: Exploring Biomarker Research Advancements

  • 

    

    Ahmed Abdelhak, MD

• 

  RestartResume

  New Consensus for Smoldering Disease in MS

  RestartResume

  New Consensus for Smoldering Disease in MS

  NeuroFrontiers

  New Consensus for Smoldering Disease in MS

• 

  RestartResume

  Discussing Disparities in MS Care for Underrepresented Populations

  RestartResume

  Discussing Disparities in MS Care for Underrepresented Populations

  NeuroFrontiers

  Discussing Disparities in MS Care for Underrepresented Populations

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

  • 

    

    Tirisham V. Gyang, MD

  • 

    

    Gopika Govindan Kutty, MD

• 

  RestartResume

  An Overview of MS Biomarkers

  RestartResume

  An Overview of MS Biomarkers

  NeuroFrontiers

  An Overview of MS Biomarkers

• 

  RestartResume

  Discussing the Latest in MS Treatment and Disease-Modifying Therapies

  RestartResume

  Discussing the Latest in MS Treatment and Disease-Modifying Therapies

  NeuroFrontiers

  Discussing the Latest in MS Treatment and Disease-Modifying Therapies

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

  • 

    

    Jay Avasarala, MD, PhD

• Previous
• 1
• 2
• …
• 17
• 18
• 19
• 20
• 21
• …
• 28
• 29
• Next